Lymph node enlargement
Updates to Article Attributes
Lymph node enlargement is often used synonymously with lymphadenopathy, which is not strictly correct.
Terminology
Lymphadenopathy is, if anything, a broader term, referring to any pathology of lymph nodes, not necessarily resulting in increased size. Indeed abnormal number of nodes, or derangement of internal architecture (e.g. cystic necrotic nodes). In addition, increase in size is not always pathologic; some nodes are bigger than other normally (e.g compare jugulodigastric nodes, to mesenteric nodes), and reactive nodes are a healthy response and do not imply pathology of the node itself.
There are approximately 600 lymph nodes, of which only some are available to direct palpation. Only some nodes in the neck, axilla and groin should ever be palpable and these should be soft and non-tender.
Pathology
Aetiology
There are many (many) causes of lymph node enlargement which include:
- infective (acute suppurative)
- reactive
:- follicular hyperplasia
- paracortical hyperplasia
- sinus histiocytosis
- granulomatous
- neoplastic
- drugs
: e, e.g.Cyclosporincyclosporin,Phenytoinphenytoin,Methotrexatemethotrexate - lipid storage diseases
- IgG4-related sclerosing disease7
By regionRadiographic appearance
The upper limit in size of a normal node varies with location, and of course the size cut off used depends on the desired sensitivity and specificity.
Cervical lymph nodes
Size criteria
- most nodes: 10 mm in short-axis
except... - sub-mental
&and sub-mandibular: 15 mm - retropharyngeal: 8 mm
There is an error error rate of ≈ 10 - 2010-20% if using size criteria alone.
The long to short-to-short axis ratio has also been proposed 2 to help evaluate enlarged nodes in the setting of head and neck SCCsquamous cell carcinoma. When nodes have a ratio of >2 (ie(i.e. long and flat) 95% are benign. When the ratio is less than 2 (i.e. rounder) then a similar proportion whereare malignant.
Size-independent criteria
- loss of fatty hilum
- focal necrosis
- cystic necrotic nodes
Mediastinal lymph nodes
In general 10 mm is considered the upper limit for normal nodes (short transverse diameter) 3-5. This does not of course take into consideration the fact that all nodal metastases must start at microscopic size, and thus using only size criteria will miss micrometastases. In the setting of lung cancer staging a sensitivity of 0.83 and a specificity of 0.82 are quoted for CT 5.
Mesenteric lymph nodes
Mesenteric nodes are increasingly visualised as visualised as a result of multidetector volume acquisition and acquisition and are most easily seen on coronal reformats.
Although 3mm3 mm had been used as the upper limit for the short axis diameter or mesenteric lymph nodes, up to 39% of healthy normal patients have larger nodes than this. As such a figure of 5mm5 mm is considered normal 6. (see: normal mesenteric lymph nodes).
See also
-<p><strong>Lymph node enlargement</strong> is often used synonymously with <strong>lymphadenopathy</strong>, which is not strictly correct. Lymphadenopathy is, if anything, a broader term, referring to any pathology of lymph nodes, not necessarily resulting in increased size. Indeed abnormal number of nodes, or derangement of internal architecture (e.g. cystic necrotic nodes). In addition, increase in size is not always pathologic; some nodes are bigger than other normally (e.g compare jugulodigastric nodes, to mesenteric nodes), and reactive nodes are a healthy response and do not imply pathology of the node itself. </p><p>There are approximately 600 lymph nodes, of which only some are available to direct palpation. Only some nodes in the neck, axilla and groin should ever be palpable and these should be soft and non-tender. </p><p>There are many (many) causes of lymph node enlargement which include : </p><ul>-<li>infective (acute suppurative)</li>-<li>reactive :-<ul>-<li>follicular hyperplasia</li>-<li>paracortical hyperplasia </li>-<li>sinus histiocytosis</li>-<li>granulomatous</li>- +<p><strong>Lymph node enlargement</strong> is often used synonymously with <strong>lymphadenopathy</strong>, which is not strictly correct.</p><h4>Terminology</h4><p>Lymphadenopathy is, if anything, a broader term, referring to any pathology of lymph nodes, not necessarily resulting in increased size. Indeed abnormal number of nodes, or derangement of internal architecture (e.g. cystic necrotic nodes). In addition, increase in size is not always pathologic; some nodes are bigger than other normally (e.g compare jugulodigastric nodes, to mesenteric nodes), and reactive nodes are a healthy response and do not imply pathology of the node itself.</p><p>There are approximately 600 lymph nodes, of which only some are available to direct palpation. Only some nodes in the neck, axilla and groin should ever be palpable and these should be soft and non-tender.</p><h4>Pathology</h4><h5>Aetiology</h5><p>There are many (many) causes of lymph node enlargement which include:</p><ul>
- +<li>infective (acute suppurative)</li>
- +<li>reactive<ul>
- +<li>follicular hyperplasia</li>
- +<li>paracortical hyperplasia </li>
- +<li>sinus histiocytosis</li>
- +<li>granulomatous</li>
-</li>-<li>neoplastic </li>-<li>drugs : e.g. Cyclosporin, Phenytoin , Methotrexate</li>-<li>lipid storage diseases </li>-</ul><h4>By region</h4><p>The upper limit in size of a normal node varies with location, and of course the size cut off used depends on the desired sensitivity and specificity. </p><a name="Cervical_Lymph_nodes:"></a><h5><span>Cervical lymph nodes</span></h5><h6>Size criteria </h6><ul>-<li>most nodes : <strong>10</strong> mm in short-axis except... </li>-<li>sub-mental & sub-mandibular : <strong>15</strong> mm </li>-<li>retropharyngeal : <strong>8</strong> mm </li>-</ul><p>There is an error rate of ≈ 10 - 20% if using size criteria alone.</p><p>The long to short axis ratio has also been proposed <sup>2</sup> to help evaluate enlarged nodes in the setting of head and neck SCC. When nodes have a ratio of >2 (ie long and flat) 95% are benign. When the ratio is less than 2 (i.e. rounder) then a similar proportion where malignant. </p><h6>Size-independent criteria </h6><ul>-<li>loss of fatty hilum </li>-<li>focal necrosis </li>-<li><a href="/articles/cystic_necrotic_nodes">cystic necrotic nodes</a></li>-</ul><h5>Mediastinal lymph nodes</h5><p>In general 10 mm is considered the upper limit for normal nodes (short transverse diameter) <sup>3-5</sup>. This does not of course take into consideration the fact that all nodal metastases must start at microscopic size, and thus using only size criteria will miss micrometastases. In the setting of lung cancer staging a sensitivity of 0.83 and a specificity of 0.82 are quoted for CT <sup>5</sup>.</p><h5>Mesenteric lymph nodes</h5><p>Mesenteric nodes are increasingly visualised as a result of multidetector volume acquisition and are most easily seen on coronal reformats. </p><p>Although 3mm had been used as the upper limit for the short axis diameter or mesenteric lymph nodes, up to 39% of healthy normal patients have larger nodes than this. As such a figure of 5mm is considered normal <sup>6</sup>. (see <a title="normal mesenteric lymph nodes" href="/articles/normal-mesenteric-lymph-nodes">normal mesenteric lymph nodes</a>)</p><h4>See also</h4><ul><li><a title="Differential diagnosis of high attenuating lymphadenopathy" href="/articles/differential-diagnosis-of-high-attenuating-lymphadenopathy">differential diagnosis of high attenuating lymphadenopathy</a></li></ul>- +</li>
- +<li>neoplastic</li>
- +<li>drugs, e.g. cyclosporin, phenytoin, methotrexate</li>
- +<li>lipid storage diseases</li>
- +<li>
- +<a title="IgG4-related sclerosing disease" href="/articles/igg4-related-sclerosing-disease-1">IgG4-related sclerosing disease</a> <sup>7</sup>
- +</li>
- +</ul><h4>Radiographic appearance</h4><p>The upper limit in size of a normal node varies with location, and of course the size cut off used depends on the desired sensitivity and specificity. </p><h5>Cervical lymph nodes</h5><h6>Size criteria</h6><ul>
- +<li>most nodes: 10 mm in short-axis</li>
- +<li>sub-mental and sub-mandibular: 15 mm</li>
- +<li>retropharyngeal: 8 mm</li>
- +</ul><p>There is an error rate of 10-20% if using size criteria alone.</p><p>The long-to-short axis ratio has also been proposed <sup>2</sup> to help evaluate enlarged nodes in the setting of head and neck squamous cell carcinoma. When nodes have a ratio of >2 (i.e. long and flat) 95% are benign. When the ratio is less than 2 (i.e. rounder) then a similar proportion are malignant.</p><h6>Size-independent criteria</h6><ul>
- +<li>loss of fatty hilum</li>
- +<li>focal necrosis</li>
- +<li><a href="/articles/cystic-necrotic-nodes">cystic necrotic nodes</a></li>
- +</ul><h5>Mediastinal lymph nodes</h5><p>In general 10 mm is considered the upper limit for normal nodes (short transverse diameter) <sup>3-5</sup>. This does not of course take into consideration the fact that all nodal metastases must start at microscopic size, and thus using only size criteria will miss <a href="/articles/micrometastases">micrometastases</a>. In the setting of lung cancer staging a sensitivity of 0.83 and a specificity of 0.82 are quoted for CT <sup>5</sup>.</p><h5>Mesenteric lymph nodes</h5><p>Mesenteric nodes are increasingly visualised as a result of multidetector volume acquisition and are most easily seen on coronal reformats. </p><p>Although 3 mm had been used as the upper limit for the short axis diameter or mesenteric lymph nodes, up to 39% of healthy normal patients have larger nodes than this. As such a figure of 5 mm is considered normal <sup>6</sup> (see: <a href="/articles/normal-mesenteric-lymph-nodes">normal mesenteric lymph nodes</a>).</p><h4>See also</h4><ul><li><a href="/articles/differential-diagnosis-of-high-attenuating-lymphadenopathy">differential diagnosis of high attenuating lymphadenopathy</a></li></ul>
References changed:
- 7. Horger M, Lamprecht HG, Bares R et-al. Systemic IgG4-related sclerosing disease: spectrum of imaging findings and differential diagnosis. AJR Am J Roentgenol. 2012;199 (3): W276-82. <a href="http://dx.doi.org/10.2214/AJR.11.8321">doi:10.2214/AJR.11.8321</a> - <a href="http://www.ncbi.nlm.nih.gov/pubmed/22915418">Pubmed citation</a><span class="auto"></span>